1. Home
  2. GOSS vs FCBC Comparison

GOSS vs FCBC Comparison

Compare GOSS & FCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • FCBC
  • Stock Information
  • Founded
  • GOSS 2015
  • FCBC 1874
  • Country
  • GOSS United States
  • FCBC United States
  • Employees
  • GOSS N/A
  • FCBC N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • FCBC Major Banks
  • Sector
  • GOSS Health Care
  • FCBC Finance
  • Exchange
  • GOSS Nasdaq
  • FCBC Nasdaq
  • Market Cap
  • GOSS 585.9M
  • FCBC 696.3M
  • IPO Year
  • GOSS 2019
  • FCBC 1992
  • Fundamental
  • Price
  • GOSS $2.41
  • FCBC $33.32
  • Analyst Decision
  • GOSS Strong Buy
  • FCBC
  • Analyst Count
  • GOSS 6
  • FCBC 0
  • Target Price
  • GOSS $8.60
  • FCBC N/A
  • AVG Volume (30 Days)
  • GOSS 3.7M
  • FCBC 44.4K
  • Earning Date
  • GOSS 11-06-2025
  • FCBC 10-24-2025
  • Dividend Yield
  • GOSS N/A
  • FCBC 3.68%
  • EPS Growth
  • GOSS N/A
  • FCBC N/A
  • EPS
  • GOSS N/A
  • FCBC 2.72
  • Revenue
  • GOSS $40,237,000.00
  • FCBC $162,762,000.00
  • Revenue This Year
  • GOSS N/A
  • FCBC $2.27
  • Revenue Next Year
  • GOSS $34.10
  • FCBC $11.13
  • P/E Ratio
  • GOSS N/A
  • FCBC $12.37
  • Revenue Growth
  • GOSS N/A
  • FCBC N/A
  • 52 Week Low
  • GOSS $0.66
  • FCBC $32.23
  • 52 Week High
  • GOSS $3.60
  • FCBC $49.02
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 44.51
  • FCBC 33.63
  • Support Level
  • GOSS $2.25
  • FCBC $32.23
  • Resistance Level
  • GOSS $2.61
  • FCBC $33.78
  • Average True Range (ATR)
  • GOSS 0.18
  • FCBC 0.81
  • MACD
  • GOSS -0.05
  • FCBC -0.09
  • Stochastic Oscillator
  • GOSS 24.58
  • FCBC 24.40

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About FCBC First Community Bankshares Inc. (VA)

First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.

Share on Social Networks: